Target intelligence / Profile preview

Autophagy-related protein (ATG)

Target
ATG
Molecular classification
Enzyme (e.g. ULK1 kinase, Atg4 protease), Ubiquitin-like conjugation system proteins (e.g. Atg8/LC3, Atg12, Atg5), Scaffold proteins (e.g. Atg13, Atg101), Lipid binding proteins (e.g. Atg18, Atg21), Regulatory and signaling proteins, Other (transporters, receptors—e.g. p62/SQSTM1 as autophagy receptor)
01

Overview

Autophagy-related proteins represent a large and conserved family of molecules essential for autophagy, a lysosome-dependent cellular process responsible for the degradation and recycling of intracellular components. These proteins are involved in a tightly regulated sequence spanning autophagosome induction (initiated by complexes containing ULK1/ULK2, Atg13, FIP200, Atg101), vesicle nucleation (Beclin-1 complex, PI3K/Vps34, Atg14, VPS15), expansion (Atg8/LC3 lipidation system, Atg12–Atg5–Atg16L1 complex), and eventual vesicle closure and fusion with lysosomes. Various subgroups and molecular classes ensure that autophagy adapts to environmental stimuli (nutrient deprivation, oxidative stress) and maintains cellular homeostasis. Mutations or dysregulation of individual ATG proteins are implicated in diverse diseases, making specific ATG proteins attractive therapeutic targets. However, “autophagy-related proteins” as a collective is less precise than naming a specific ATG protein, and refers to the broader set of conserved molecules with roles in autophagy regulation, membrane dynamics, cargo recognition, and trafficking.

Other names
ATG proteinsAutophagy proteinsMacroautophagy proteinsBeclin-1 (ATG6)ULK1LC3 (ATG8)Atg4Atg12Atg16L1
02

Mechanism of action

Induction of autophagy via inhibition of mTOR/activation of ULK1 complex; Inhibition of autophagy via lysosomal pH modulation (chloroquine class); Modulation of Beclin 1-Bcl-2 protein-protein interactions to regulate autophagosome formation; Ubiquitin-like conjugation for membrane expansion (Atg8/LC3 lipidation, Atg12-Atg5 system).

03

Biological functions

Cellular degradation and recyclingAutophagosome formation—initiation, nucleation, expansion, closureVesicle trafficking and membrane dynamicsRegulate cell survival under stress/starvationCrosstalk with apoptosisAdaptation to stressImmune response modulation
04

Disease associations

Cancer (defective autophagy linked to tumorigenesis; ATG proteins as targets)Neurodegenerative diseases (e.g., Parkinson’s, Alzheimer’s—misfolded protein clearance)Inflammation (dysregulated autophagy contributes to chronic inflammatory diseases)Infection (host-pathogen interactions; some pathogens modulate autophagy)Other: Metabolic syndrome, Crohn disease (certain ATG variants)
05

Safety considerations

Excess autophagy: cell death, tissue damageInsufficient autophagy: accumulation of damaged proteins/organelles, tumorigenesis, neurodegenerationToxicity in autophagy inhibitors: e.g. chloroquine class, lysosomal damageOff-target effects due to broad involvement of autophagy in health and disease
06

Interacting drugs

Rapamycin/everolimus (mTOR inhibitors—indirectly induce autophagy via mTOR/ULK1 inhibition)

3 more in the full profile.

07

Biomarkers

LC3-II (lipidated LC3, autophagosome membrane marker)p62/SQSTM1 (autophagy receptor; accumulation indicates blocked autophagy)Beclin-1 expression levelsATG gene mutations, e.g. Atg16L1 in Crohn disease

Beyond the preview

Go deeper on Autophagy-related protein (ATG).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Autophagy-related protein (ATG).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call